Trump announces nine pharmaceutical companies will offer discounted drug prices

President Trump announced that nine pharmaceutical companies will sell their drugs to state Medicaid programs at discounted prices under his 'most favored nation' pricing system. The announcement was made during remarks in the Oval Office, where he was accompanied by aides and business executives. The nine companies involved are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. Trump emphasized that his program aims to ensure that the sticker prices for prescription drugs match or are lower than prices charged overseas. He has positioned these efforts as a response to voter concerns about inflation and drug affordability. However, it remains uncertain how much savings will actually be realized by consumers, as insurance typically pays at a discount. The administration has claimed potential savings of more than $500 billion over a decade.